[Interferon (Egiferon) therapy of chronic active hepatitis].
Human leukocyta interferon (Egiferon) has been administered in 10 cases having HBsAg positive chronic active hepatitis. The treatment was started with 3 x 3 MU week for one month and either with 2 x 3 MU week or 3 x 3 MU week for 2 subsequent months. HBsAg negativity was found in cases of 4 and histological improvement in cases of 3 patients. The treatment was ineffective in 3 cases.
Ibrányi
E
E
Semmelweis Orvostudományi Egyetem I. Belklinika, Fövárosi Szent László Kórház V. Belgyógyászat.
Nagy
E
E
Szalay
F
F
Horváth
G
G
Dávid
K
K
D002908:Chronic Disease; D004305:Dose-Response Relationship, Drug; D005260:Female; D006509:Hepatitis B / Q000188:drug therapy; D006514:Hepatitis B Surface Antigens / Q000276:immunology; D006801:Humans; D007372:Interferons / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male
D006514:Hepatitis B Surface Antigens; D007372:Interferons